Significantly more infusion centers than expected are ready to give patients suffering from Alzheimer's disease Biogen's new medication Aduhelm, according to Fiercepharma.
900 infusion centers will be poised to administer this medication when Biogen starts shipping it in two weeks' time. In April, the estimated number of infusion centers was 600. In total, the US company estimates that 1,200 clinics around the US will be able to administer Aduhelm.
Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
More from MedWatch
More disappointment for Orphazyme as FDA rejects Niemann Pick C application
The FDA have rejected an application for marketing authorization for Orphazyme's main drug candidate, arimoclomol, as a treatment for metabolic disease Niemann Pick C. The authority wants more data.
Orphazyme CEO silent on potential firings in wake of FDA rejection
The FDA rejection of Orphazyme's drug candidate in its main indication will trigger major cuts at the biotech firm, but CEO Christophe Bourdon has no comment on where they will be implemented and how hard the US organization will be hit.
Orphazyme cuts guidance following FDA setback
Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.
Top Orphazyme figure on FDA rejection: "It is very disappointing and very unexpected"
Biotech heavyweight Bo Jesper Hansen is very disappointed over the FDA rejection of Orphazyme's only drug candidate.
US OTC hearing aid channel back on Department of Health agenda
The US health department aims to have a hearing on publishing the regulatory framework for selling hearing aids over the course of the year.
Formulation Specialist, Oral Formulation Research - Novo Nordisk 
Clinical Supply Manager/Specialist - Lundbeck 
Project Assistant, Translational medicine - Y-mAbs Therapeutics 
Chemist responsible for validation and qualification for Laboratory Automation Development 
Head of Development Operations - Genmab 
Employee for regulatory department 
Clinical Supply Coordinator - Klifo 
Analytical Coordinator (Senior scientist) – Permanent position, Symphogen 
(Senior) Regulatory Science Specialist - IWA Consulting 
Regulatory affairs life cycle specialist